Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J Grillo-López, Christine A. White et al. · Blood · 1997 · 1.7K citations

Medicine, Hematology, Oncology +14

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

Daniel Albert, Jonathan Dunham, Shaheen Khan et al. · Annals of the Rheumatic Diseases · 2008 · 207 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Nicky Dunn, Alexander Juto, Malin Ryner et al. · Multiple Sclerosis Journal · 2017 · 104 citations

Life Sciences, Immunology, Internal Medicine +16

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

Kenji Ishikura, Kazushi Tsuruga, Koichi Nakanishi et al. · Clinical and Experimental Nephrology · 2015 · 87 citations

Medicine, Nephrology, Pediatrics +12